Dr. Miyazawa presented his research results on “Genome-wide Analysis Reveals Novel Mechanisms Underlying Atrial Fibrillation and the Clinical Utility of a Polygenic Predictor for Cardioembolic Risk”at the American Society of Human Genetics 2022 annual meeting held in Los Angeles, CA, USA.